Now showing items 1-1 of 1

    • OX40 and 4-1BB delineate distinct immune profiles in sarcoma. 

      Melake, MJ; Smith, HG; Mansfield, D; Davies, E; Dillon, MT; et al. (TAYLOR & FRANCIS INC, 2022-12-31)
      Systemic relapse after radiotherapy and surgery is the major cause of disease-related mortality in sarcoma patients. Combining radiotherapy and immunotherapy is under investigation as a means to improve response rates. ...